Reig M - Search Results

1

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.

Rimassa L, Assenat E, Peck-Radosavljevic M, Pracht M, Zagonel V, Mathurin P, Rota Caremoli E, Porta C, Daniele B, Bolondi L, Mazzaferro V, Harris W, Damjanov N, Pastorelli D, Reig M, Knox J, Negri F, Trojan J, López López C, Personeni N, Decaens T, Dupuy M, Sieghart W, Abbadessa G, Schwartz B, Lamar M, Goldberg T, Shuster D, Santoro A, Bruix J. Rimassa L, et al. Among authors: reig m. Lancet Oncol. 2018 May;19(5):682-693. doi: 10.1016/S1470-2045(18)30146-3. Epub 2018 Apr 3. Lancet Oncol. 2018. PMID: 29625879 Clinical Trial.

2

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

Forner A, Ayuso C, Varela M, Rimola J, Hessheimer AJ, de Lope CR, Reig M, Bianchi L, Llovet JM, Bruix J. Forner A, et al. Among authors: reig m. Cancer. 2009 Feb 1;115(3):616-23. doi: 10.1002/cncr.24050. Cancer. 2009. PMID: 19117042 Free article.

3

New drugs for the treatment of hepatocellular carcinoma.

Boucher E, Forner A, Reig M, Bruix J. Boucher E, et al. Among authors: reig m. Liver Int. 2009 Jan;29 Suppl 1:148-58. doi: 10.1111/j.1478-3231.2008.01929.x. Liver Int. 2009. PMID: 19207980 Review.

4

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

Forner A, Reig M, Bruix J. Forner A, et al. Among authors: reig m. Gastroenterology. 2009 Jul;137(1):26-9. doi: 10.1053/j.gastro.2009.05.014. Epub 2009 May 29. Gastroenterology. 2009. PMID: 19482098 No abstract available.

5

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Rimola J, et al. Among authors: reig m. Hepatology. 2009 Sep;50(3):791-8. doi: 10.1002/hep.23071. Hepatology. 2009. PMID: 19610049

6

Sorafenib for hepatocellular carcinoma: global validation.

Reig M, Bruix J. Reig M, et al. Gastroenterology. 2009 Sep;137(3):1171-3. doi: 10.1053/j.gastro.2009.07.008. Epub 2009 Jul 24. Gastroenterology. 2009. PMID: 19632249 No abstract available.

7

Medical treatments: in association or alone, their roles and their future perspectives: the Western experience.

Reig M, Bruix J. Reig M, et al. J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):420-1. doi: 10.1007/s00534-009-0237-9. Epub 2009 Nov 5. J Hepatobiliary Pancreat Sci. 2010. PMID: 19890601 Review.

8

[Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers].

Varela M, Reig M, de la Mata M, Matilla A, Bustamante J, Pascual S, Turnes J, Aracil C, Del Val A, Pascasio JM, Rodríguez M, Bruix J. Varela M, et al. Among authors: reig m. Med Clin (Barc). 2010 May 8;134(13):569-76. doi: 10.1016/j.medcli.2009.10.042. Epub 2009 Dec 29. Med Clin (Barc). 2010. PMID: 20036398 Spanish.

9

Current strategy for staging and treatment: the BCLC update and future prospects.

Forner A, Reig ME, de Lope CR, Bruix J. Forner A, et al. Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19. Semin Liver Dis. 2010. PMID: 20175034 Review.

10

[Treatment of advanced hepatocellular carcinoma].

Forner A, Rodríguez De Lope C, Reig M, Bruix J. Forner A, et al. Among authors: reig m. Gastroenterol Hepatol. 2010 Jun-Jul;33(6):461-8. doi: 10.1016/j.gastrohep.2009.12.006. Epub 2010 Mar 15. Gastroenterol Hepatol. 2010. PMID: 20227796 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page